Clinical Study
Serum β-Catenin Levels Associated with the Ratio of RANKL/OPG in Patients with Postmenopausal Osteoporosis
Table 2
Associations of serum β-catenin with other parameters in PMOP group and control group.
| | PMOP group | Control group | | | | | |
| Age | | 0.525 | | 0.301 | Weight | | 0.400 | | 0.536 | Height | 0.038 | 0.402 | | 0.312 | BMI | | 0.010 | | 0.641 | BMD | | <0.001 | | 0.294 | T-score | | <0.001 | | 0.272 | Estradiol | 0.033 | 0.470 | | 0.269 | N-MID-OT | 0.070 | 0.125 | | 0.542 | 25(OH)D | | 0.493 | | 0.956 | CTX | 0.050 | 0.277 | | 0.862 | PINP | 0.033 | 0.469 | | 0.811 | Sclerostin | | <0.001 | 0.145 | 0.060 | OPG | 0.232 | <0.001 | 0.112 | 0.145 | RANKL | 0.067 | 0.143 | 0.134 | 0.081 | Ratio of RANKL/OPG | | 0.005 | 0.032 | 0.674 |
|
|
The table shows Spearman’s correlation coefficients () and associated P values (P) in PMOP group and in control group.
|